The core binding factor (CBF) α interaction domain and the smooth muscle myosin heavy chain (SMMHC) segment of CBFβ-SMMHC are both required to slow cell proliferation

被引:39
作者
Cao, WS
Adya, N
Britos-Bray, M
Liu, PP
Friedman, AD
机构
[1] Johns Hopkins Oncol Ctr, Div Pediat Oncol, Baltimore, MD 21287 USA
[2] NHGRI, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.273.47.31534
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have expressed several variants of core binding factor beta (CBF beta)-smooth muscle myosin heavy chain (SMMHC) from the metallothionein promoter in Ba/F3 cells. Deletion of amino acids 2-11 from the CBF beta segment, required for interaction with CBF alpha, prevented CBF beta-SMMHC from inhibiting CBF DNA binding and cell cycle progression. Deletion of 283 carboxyl-terminal residues from the SMMHC domain, required for multimerization, also inactivated CBF beta-SMMHC. Nuclear expression of CBF beta(Delta 2-11)-SMMHC was decreased relative to CBF beta-SMMHC. CBF beta(Delta 2-11)-SMMHC linked to a nuclear localization signal still did not slow cell growth. The ability of each CBF beta-SMMHC variant to inhibit CBF DNA binding and cell proliferation correlated with its ability to inhibit transactivation by an AML1-VP16 fusion protein. Thus, CBF beta-SMMHC slows cell cycle progression from G(1) to S phase by inhibiting CBF DNA binding and transactivation.
引用
收藏
页码:31534 / 31540
页数:7
相关论文
共 45 条
[1]  
ADYA N, 1998, IN PRESS MOL CELL BI
[2]   Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO(MTG8) [J].
Ahn, MY ;
Huang, G ;
Bae, SC ;
Wee, HJ ;
Kim, WY ;
Ito, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1812-1817
[3]  
BAE SC, 1993, ONCOGENE, V8, P809
[4]   Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb [J].
BritosBray, M ;
Friedman, AD .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5127-5135
[5]  
BRITOSBRAY M, 1998, IN PRESS BLOOD
[6]   CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells [J].
Cao, WS ;
BritosBray, M ;
Claxton, DF ;
Kelley, CA ;
Speck, NA ;
Liu, PP ;
Friedman, AD .
ONCOGENE, 1997, 15 (11) :1315-1327
[7]   Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11 [J].
Castilla, LH ;
Wijmenga, C ;
Wang, Q ;
Stacy, T ;
Speck, NA ;
Eckhaus, M ;
MarinPadilla, M ;
Collins, FS ;
WynshawBoris, A ;
Liu, PP .
CELL, 1996, 87 (04) :687-696
[8]  
Frank R, 1995, ONCOGENE, V11, P2667
[9]  
Golling G, 1996, MOL CELL BIOL, V16, P932
[10]   FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
GOLUB, TR ;
BARKER, GF ;
BOHLANDER, SK ;
HIEBERT, SW ;
WARD, DC ;
BRAYWARD, P ;
MORGAN, E ;
RAIMONDI, SC ;
ROWLEY, JD ;
GILLILAND, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4917-4921